Zydus Lifesciences Limited
PPFAS Mutual Fund decreased its stake in Zydus Lifesciences from 2.02% to 2.01%, selling 58,129 shares.
A vertically integrated pharmaceutical company, Zydus Lifesciences develops, manufactures, and markets generic drugs, specialty pharmaceuticals, and biologics for domestic and international markets. The company operates across multiple therapeutic areas including cardiology, gastroenterology, oncology, and immunology. It serves patients globally through its extensive distribution network, research capabilities, and commitment to addressing unmet healthcare needs across diverse populations and geographies.
Founded by Parag Parikh Financial Advisory Services, best known for the Parag Parikh Flexi Cap Fund which invests in both Indian equities and select global large-caps including Meta, Alphabet, and Microsoft. Manages over Rs 1.2 lakh crore with a concentrated, long-duration, value-focused approach. CIO Rajeev Thakkar is one of India's most respected investors with a Munger-influenced thinking style.